Holen Sie sich die Stockscreener-App
130.17
0.80%
1.03
Handel nachbörslich:
129.80
-0.37
-0.28%
Guardant Health Inc Aktie (GH) Neueste Nachrichten
GH Assumed by Wolfe Research -- Rating Set to Outperform - GuruFocus
Guardant Health Coverage Assumed by Wolfe Research at Outperform - Moomoo
This Evercore ISI Group Analyst Turns Bullish; Here Are Top 2 Upgrades For Tuesday - Benzinga
Guardant Health (NASDAQ: GH) director settles 154 RSUs, holds 19,516 shares - Stock Titan
Wolfe Research initiates Guardant Health stock with outperform rating By Investing.com - Investing.com Canada
3 Reasons GH is Risky and 1 Stock to Buy Instead - Yahoo Finance
Guardant Health, Inc. (GH) Stock Analysis: Navigating the Rapid Growth in Precision Oncology - DirectorsTalk Interviews
Blood testing is now included in screening recommendations for colon and rectal cancer - WQOW
Guardant Health Reaches New 52-Week High of $133.70 - Markets Mojo
Guardant Health director sells $130,060 of common stock - Investing.com UK
What Drove Guardant Health's Q4 2025 Performance and 2026 Outlook - Kavout
Guardant Health director sells $130,060 of common stock By Investing.com - Investing.com Australia
Guardant Health (GH) director sells 1,000 shares, retains 639 - Stock Titan
Guardant Health stock hits 52-week high at 133.97 USD By Investing.com - Investing.com Nigeria
A Quick Look at Today's Ratings for Guardant Health(GH.US), With a Forecast Between $130 to $135 - Moomoo
Guardant Health stock hits 52-week high at 133.97 USD - Investing.com
Testing & Diagnostics Services Stocks Q1 Earnings: Guardant Health (NASDAQ:GH) Firing on All Cylinders - Yahoo Finance
Guardant Health Insider Sold Shares Worth $1,250,836, According to a Recent SEC Filing - Moomoo
Guardant Health Stock Rockets 40% With 8-Day Winning Streak - Trefis
8-Day Rally Sends Guardant Health Stock Up 40% - Trefis
Guardant Health CLO John Saia sells $1.25 million in shares By Investing.com - Investing.com Australia
Guardant Health CLO John Saia sells $1.25 million in shares - Investing.com
Guardant Health (GH) legal chief sells 10,000 shares in open-market trades - Stock Titan
Guardant Health (NASDAQ: GH) notice: proposed sale of 1,000 shares - Stock Titan
A Quick Look at Today's Ratings for Guardant Health(GH.US), With a Forecast Between $130 to $160 - Moomoo
Guardant Health and Collaborators to Present 38 Abstracts Highlighting Breadth and Expanded Clinical Utility of Guardant Liquid Biopsy Tests Powered by InfinityAI at 2026 ASCO Annual Meeting - BioSpace
Stifel reiterates Guardant Health stock rating on screening outlook - Investing.com
Stifel reiterates Guardant Health stock rating on screening outlook By Investing.com - Investing.com Canada
Blood tests for cancer: 38 Guardant studies at 2026 ASCO meeting - Stock Titan
Guardant Health Stock Rockets 34% With 7-Day Winning Streak - Trefis
Guardant Health Stock On Fire: Up 34% With 7-Day Winning Streak - Trefis
Why This Medtech Stock Just Bulled Through A Buy Point - Investor's Business Daily
Baron Health Care Fund Q1 2026 Portfolio Activity - Seeking Alpha
Guardant Health climbs as FDA-related momentum and an analyst price-target hike fuel gains - Quiver Quantitative
Sector Update: Health Care Stocks Mixed Premarket Wednesday - Moomoo
American Cancer Society Recommends Guardant Health’s Shield Blood Test in Updated Colorectal Cancer Screening Guidelines - 01net
Sector Update: Healthcare - Moomoo
Blood test added to US colorectal cancer screening options - Reuters
New blood test added to help screen 50M Americans for colorectal cancer - Stock Titan
GH Stock Price, Quote & Chart | GUARDANT HEALTH INC (NASDAQ:GH) - ChartMill
Guardant Health Stock Surges 26%, With A 6-Day Winning Spree - Trefis
Guardant Health Stock On Fire: Up 26% With 6-Day Winning Streak - Trefis
Guardant Health CCO Chris Freeman sells $2.9m in company stock By Investing.com - Investing.com South Africa
Guardant Health CCO Chris Freeman sells $2.9m in company stock - Investing.com Australia
Guardant Health Insider Sold Shares Worth $2,896,360, According to a Recent SEC Filing - Moomoo
Guardant Health (GH) CCO exercises options, sells 24,406 common shares - Stock Titan
BTIG Maintains Guardant Health(GH.US) With Buy Rating, Raises Target Price to $155 - Moomoo
BTIG raises Guardant Health stock price target on FDA approval By Investing.com - Investing.com Canada
BTIG raises Guardant Health stock price target on FDA approval - Investing.com
Guardant Health, Inc. (GH) Stock Analysis: 48.3% Revenue Growth Fuels Investor Optimism - DirectorsTalk Interviews
Guardant gets FDA nod for next-gen cancer mutation blood test - Mugglehead Investment Magazine
Guardant Health (GH) Stock Price, News & Analysis $GH - MarketBeat
0.50%
1.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):